What is it about?
We report a novel compound that has effects on weight loss, insulin resistance, glucose intolerance, hyperlipidemia, and non-alcoholic fatty liver disease without changes in food intake, physical activity and thyroid hormone axis.
Featured Image
Read the Original
This page is a summary of: A Small Molecule, UAB126, Reverses Diet-Induced Obesity and its Associated Metabolic Disorders, Diabetes, July 2020, American Diabetes Association,
DOI: 10.2337/db19-1001.
You can read the full text:
Contributors
The following have contributed to this page
